Home > Back to Publisher > Report Information

Vaccines: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry

Kalorama Information
April 1, 2008
230 Pages - SKU: KLI1682234

Attention: There is an updated edition available for this report.

Abstract Table of Contents Search inside this report Related Reports

Countries covered: Global

Few areas of pharmaceuticals have seen the fast-moving developments in the marketplace that the vaccine market has in 2007 and 2008. Since Kalorama Information last updated Kalorama Information's The World Market for Vaccines in the first quarter of last year, new products and better than expected profits have transformed the vaccine marketplace. Approvals that have been granted for products such as RotaTeq, Pentacel, Adacel and Zostavax and FluMist are now impacting the market. The launch and execution of the first successful cancer vaccine product, Merck's Gardasil, has had dramatic and surprising results. Other products also exceeded revenue expectations. The competitive dynamics have changed with merger activity, and many new products are on the way.

Kalorama vaccine market analyst Allison Sahoo's exhaustive research and analysis of interviews with key decision makers in the market includes the following:

Review of Products in the Market
Current World Market Size for Pediatric and Adult Vaccines
Segmented Revenues and Forecasts to 2013 by Category
Over 45 Charts and Tables To Make Information Accessible
Important Vaccines and Immunization Schedules and Statistics
Discussion of Issues and Trends in the Vaccine Market
Profiles of 15 Key Vaccine Companies
Thorough Review of the Vaccine Pipeline and Possible Impact of New Products

Who are the main players in the vaccine market? What opportunities are available for pharmaceutical companies or investors from this market? What are the potential challenges vaccine competitors must deal with? What will be the impact of the first successful cancer product? What is the significance of at least one major acquisition to affect this industry? These questions and more are tackled in this report.

Current revenues and revenue forecasts to 2013 are included for the following pediatric vaccine categories:

DTaP & DTP Vaccines
Hep Vaccines
HiB Vaccines
MMR Vaccines
Combination Vaccines
Pneumococcal Vaccines
Polio Vaccines
Varicella Vaccines
Other Pediatric Vaccines

As well as Revenues and Forecasts to 2012 for the following adult vaccine categories:

Influenza Vaccines
Hepatitis Vaccines
Pneumococcal Vaccines
Travel, DT and other Adult Vaccines
Cervical Cancer

This is a rapidly changing marketplace and knowledge of the R&D pipeline is essential to truly understand what is happening in vaccines. Vaccines in development are discussed in this report, including vaccines for the following conditions:

Enterotoxigenic Escherichia coli
Parainfluenza Virus Type 3
Pneumococcal Vaccines
Respiratory Syncytial Virus<
Cancers
Cholera
HIV/AIDS
Helicobacter Pylori
Malaria
Rabies
Tuberculosis
West Nile Virus

This Kalorama Information report was created with a primary research effort - interviews with market experts in the vaccine market who shared insights, informed of new trends and helped to construct models, supplemented by secondary research in company, medical and trade literature. Marketing and Business Development executives, strategic planners, research and development executives, as well as investors and financial consultants are among those who will find this a useful resource.

CHAPTER ONE: EXECUTIVE SUMMARY: The Global Vaccine Industry; The Market; The Market; Total Vaccine Market; Issues and Trends; A “Gardasil Effect” in R&D?
CHAPTER TWO: INTRODUCTION TO VACCINES: A Brief History: The Development of Vaccines; The Immune Response; Mechanism of Action; Types of Vaccines; Vaccine Approval Process
CHAPTER THREE: PEDIATRIC VACCINES: Introduction; Childhood Immunization in the United States; Pediatric Vaccine Products; Cost of Vaccines in the United States; Pediatric Vaccines in Development; The World Market for Pediatric Preventive Vaccines
CHAPTER FOUR: ADULT PREVENTIVE VACCINES: Introduction; Adult Vaccine-Preventable Diseases: Facts and Figures; Global Virological Surveillance Program; Recommendations for Adult Immunizations; Adult Vaccine Products; Adult Vaccines in Development; Global Initiatives for Vaccine Research; The World Market for Adult Preventive Vaccines
CHAPTER FIVE: VACCINES MARKET SUMMARY: Trends Driving the Vaccines Market; Market Size and Forecast
CHAPTER SIX: ISSUES AND TRENDS: Resistance to Immunization; Vaccine Safety; Increased US Vaccine Availability; Vaccine Shortages; A 'Gardasil Effect' in R&D?; Vaccines and Bioterrorism; DNA Vaccination; Innovations in Vaccine Delivery Systems
CHAPTER SEVEN: COMPANY PROFILES: Acambis plc; AlphaVax, Inc.; Avant Immunotherapeutics; Bavarian Nordic A/S; Baxter Healthcare; Crucell; Emergent biosolutions; GlaxoSmithKline; Medimmune; Merck & Co. Inc; Nabi Biopharmaceuticals; Novartis; Pfizer; Pharmexa; Sanofi Pasteur; Wyeth
APPENDIX: COMPANY DIRECTORY
TABLE OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY: Figure 1-1: World Market for Pediatric Vaccines 2004-2013 Revenues; Figure 1-2: World Market for Adult Vaccines 2004-2013 Revenues
CHAPTER TWO: INTRODUCTION TO VACCINES: Table 2-1: Impact of Vaccines in the 20th Century Annual Morbidity in the 20th Century vs 2006; Table 2-2: Vaccine-Preventable Diseases, April 2008
CHAPTER THREE: PEDIATRIC PREVENTIVE VACCINES: Table 3-1: Global Immunization Rates by Vaccine Type 2006; Table 3-2: Immunization Profile of the United States: Population by Age Group, Number of Vaccine-Preventable Diseases Reported by Disease 2000-2006; Table 3-3: U.S. Recommended Childhood Immunization Schedule, 2008; Table 3-4: U.S. Recommended Adolescent Immunization Schedule, 2008; Table 3-5: Selected Pediatric Vaccines in Development, April 2008; Table 3-6: World Market for Pediatric Vaccines by Type (DTaP/DTP, Hep, HiB, MMR, Combos, Pneumococcal, Polio, Varicella, Others) 2004-2013; Figure 3-1: Market Share of Pediatric Vaccines by Type 2007; Figure 3-2: Market Share of Pediatric Vaccines, by Type 2013; Table 3-7: World DTP and DTaP Vaccine Market 2004-2013; Table 3-8: World Pediatric Hepatitis Vaccine Market 2004-2013; Table 3-9: World Hib Vaccine Market, 2004-2013; Table 3-10: World MMR Vaccines Market 2004-2013; Table 3-11: World Combination Vaccines Market 2004-2013; Table 3-12: World Pediatric Pneumococcal Vaccine Market 2004-2013; Table 3-13: World Poliovirus Vaccine Market 2004-2013; Table 3-14: World Varicella Vaccine Market 2004-2013; Table 3-15: Other Vaccines Market 2004-2013
CHAPTER FOUR: ADULT PREVENTIVE VACCINES: Table 4-1: Universal Adult Immunization Schedule 2008; Table 4-2: Adult Immunization Schedule for Populations with Special Medical Conditions, 2008; Table 4-3: Initiatives to Require HPV Vaccination by U.S. State, 2008; Table 4-4: Selected Adult Preventive Vaccines in Development, 2008; Table 4-5: World Market for Adult Preventive Vaccines by Type (Hepatitis, Influenza, Pneumococcal, Travel/DT/Misc.), 2004-2013; Figure 4-1: Market Share of Adult Vaccines, by Type, 2007 (Cervical Cancer, Hepatitis, Influenza, Pneumococcal, Travel); Figure 4-2: Market Share of Adult Vaccines, by Type, 2013; Table 4-6: World Cervical CancerVaccine Market 2004-2013; Table 4-7: World Hepatitis Vaccine Market 2004-2014; Table 4-8: World Influenza Vaccine Market 2004-2013; Table 4-9: CDC Goal to Double Flu Immunization by 2010 Group and Estimated Immunization Rate (2000 vs 2010); Table 4-10: 2007 Estimated Population by Region and Selected Age Group; Table 4-11: World Pneumococcal Vaccine Market 2004-2013; Table 4-12: World Travel; Diphtheria-Tetanus; Miscellaneous Vaccines Market 2004-2013
CHAPTER FIVE: VACCINES MARKET SUMMARY: Table 5-1: The World Vaccines Market by Vaccine Type 2004-2013; Figure 5-1: World Market for Vaccines by Type 2004-2013; Figure 5-2: World Market for Vaccines Share by Type, 2004, 2007 and 2013; Table 5-2: Major Manufacturers’ Shares of the World Vaccine Market, 2007 154 Figure 5-3: 2007 World Vaccines Market Share, by Leading Competitors 155 Table 5-3: Major Manufacturer’s Shares of the World Pediatric Vaccine Market 2007; Figure 5-5: Market Share of Pediatric Vaccines Market, 2007 157 Table 5-4: Major Manufacturer’s Shares of the World Adult Vaccine Market 2007; Figure 5-6: Market Share of Adult Vaccines Market 2007
CHAPTER SIX: ISSUES AND TRENDS: Table 6-1: Selected Companies/Laboratories Developing Biodefense Vaccines

More Global Allergy/Immunology Reports

The World Market for Over The Counter (OTC) Drugs by Kalorama Information
Over-the-counter (OTC), non-legend, and non-prescription are all adjectives describing drugs that an individual may purchase without a prescription. Many pharmaceutical companies seeking more revenue and ...

Nasal Congestion Global Clinical Trials Review, H1, 2012 by GlobalData
Nasal Congestion Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Nasal Congestion Global Clinical Trials Review, H1, 2012 provides data on the Nasal Congestion ...

Food Allergy and Intolerance Products by Global Industry Analysts
This report analyzes the worldwide markets for Food Allergy and Intolerance Products in US$ Million by the following product segments: Gluten-free, and Others. The report ...

The 2011-2016 World Outlook for Non-Prescription Decongestants Excluding Nasal Sprays and Nose Drops by Icon Group International, Inc.
This econometric study covers the world outlook for non-prescription decongestants excluding nasal sprays and nose drops across more than 200 countries. For each year reported, ...

Nicholas Hall's Global Cough, Cold & Allergy Review by Nicholas Hall and Company
This essential report is the ideal guide to CCA brands and marketers across leading developed and emerging markets, focusing on core trends and exciting developments. ...

See all reports like this >>

Vaccines: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry

Share this report

Other tasks

Research Assistance

Related Markets

Allergy/Immunology Reports

Free Alert Me service